A revolutionary stem-cell therapy must proceed responsibly to achieve its full potential

TL;DR - This Nature editorial argues that induced pluripotent stem-cell therapies must advance responsibly as clinical trials accelerate. Maintaining public trust will be essential for the technology to realize its medical potential.

• Induced pluripotent stem cells have influenced biomedical research for 20 years.
• Stem-cell-based interventions are now being evaluated in clinical trials.
• Responsible clinical development and public trust are presented as central priorities.
• The provided excerpt does not describe specific therapies, trial results or safety outcomes.